← Open Payments lookup

JOLYN HOLLIDAY VEZA: Open Payments

NPI 1871848770 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,406 in 178 payments from 40 companies in 2025. Trend: 2023 $3,660 · 2024 $4,492 · 2025 $4,406

Food & beverage: $3,219Long term medical supply or device loan: $1,000Education: $188
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation33$1,324
Gilead Sciences, Inc.8$239
PFIZER INC.12$222
Janssen Biotech, Inc.10$221
Exelixis Inc.10$218
Merck Sharp & Dohme LLC10$210
Daiichi Sankyo Inc.10$205
Eisai Inc.9$185
AstraZeneca Pharmaceuticals LP9$174
ABBVIE INC.5$114

Products named: KISQALI, CABOMETYX, Trodelvy, Enhertu, KEYTRUDA, Lenvima, REBLOZYL, VENCLEXTA.

Industry payments across IN — which companies pay providers there.